Amy Emerson, Lykos Therapeutics CEO
Psychedelic-assisted drug developer MAPS PBC nabs $100M, renames to Lykos Therapeutics
MAPS Public Benefit Corporation, a California biotech attempting to bring MDMA-assisted therapy to market for mental health conditions, said it has raised more than …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.